Select Committee on Public Administration Appendices to the Minutes of Evidence


Memorandum by United Bristol Healthcare NHS Trust (PST 42)

  Following my meeting with PASC on Tuesday 10 December I would like to respond to your request to respond in detail to the questions in the paper.

  Q15: There is a strong sense that NHS targets are introduced without any attempt at piloting or feedback and that front line clinicians have not been consulted.

  Q27: The waiting time targets for new outpatient appointments at the Bristol Eye Hospital have been achieved at the expense of cancellation and delay of follow-up appointments. At present we cancel over 1,000 appointments per month. Some patients have waited 20 months longer than the planned date for their appointment.

  We have kept clinical incident forms for all patients, mostly those with glaucoma or diabetes, who have lost vision as a result of delayed follow-up; there have been 25 in the past two years. This figure undoubtedly underestimates the true incidence and of course there is the large backlog of patients still to be seen. One particularly sad case was that of an elderly lady who was completely deaf and relied upon signing and lip-reading for communication. She lives with her disabled husband who like her is completely deaf. Her follow-up appointment for glaucoma was delayed several times and during this time her glaucoma deteriorated and she became totally blind.

  In addition to the distressing consequences for the patients, the staff at the hospital have to deal with a huge number of phone calls and letters often from patients who are anxious and upset. Doctors' time is spent responding to 200 letters per week requesting that appointments be re-instated. This activity is extremely time consuming and demoralising for all staff.

  The outpatient waiting time target for new patients has been introduced without sufficient resources and we have already employed nurse practitioners and optometrists wherever it is possible to do so and taken all possible measures to improve efficiency; inevitably there have been adverse consequences for other areas of activity.

  Q31: Targets in themselves are not bad. However, it is important to choose the right targets and to monitor their effects. When hospital trusts are assessed, other factors such as CHI assessments, research productivity and clinical outcomes should be taken into account as well as the star-rating targets.

Richard A Harrad

Clinical Director, Bristol Eye Hospital


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2003
Prepared 16 July 2003